Novartis Ag (NVSEF) Net Income towards Common Stockholders (QoQ) (2009 - 2026)

Novartis Ag (NVSEF) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2026	30.95%
Dec 31, 2025	-38.24%
Sep 30, 2025	-1.45%
Jun 30, 2025	13.11%
Mar 31, 2025	28.87%
Dec 31, 2024	-10.13%
Sep 30, 2024	-1.25%
Jun 30, 2024	22.14%
Mar 31, 2024	-68.36%
Dec 31, 2023	387.06%
Sep 30, 2023	-23.42%
Jun 30, 2023	1.83%
Mar 31, 2023	57.97%
Dec 31, 2022	-5.48%
Sep 30, 2022	-5.19%
Jun 30, 2022	-23.00%
Mar 31, 2022	-86.28%
Dec 31, 2021	492.68%
Sep 30, 2021	-4.65%
Jun 30, 2021	41.76%